230 related articles for article (PubMed ID: 24308704)
1. Role of immunohistochemistry for hepatitis D and hepatitis B virus in hepatitis delta.
Kabaçam G; Wedemeyer H; Savaş B; Keskin O; Dalekos G; Tabak F; Idilman R; Erhardt A; Yalçın K; Bozdayi MA; Bozkaya H; Manns M; Dienes H; Yurdaydın C;
Liver Int; 2014 Sep; 34(8):1207-15. PubMed ID: 24308704
[TBL] [Abstract][Full Text] [Related]
2. [Immunohistochemical study of hepatitis B and D virus antigens (HBsAg, HBcAg, HDAg) in chronic liver diseases].
Horváth G; Stotz G; Schaff Z; Tolvaj G; Dávid K
Orv Hetil; 1996 May; 137(21):1133-8. PubMed ID: 8757107
[TBL] [Abstract][Full Text] [Related]
3. Loss of intrahepatic HBsAg expression predicts sustained response to peginterferon and is reflected by pronounced serum HBsAg decline.
Arends P; Rijckborst V; Zondervan PE; Buster E; Cakaloglu Y; Ferenci P; Tabak F; Akarca US; Simon K; Sonneveld MJ; Hansen BE; Janssen HL
J Viral Hepat; 2014 Dec; 21(12):897-904. PubMed ID: 24444353
[TBL] [Abstract][Full Text] [Related]
4. [The intrahepatic expression of the hepatitis B virus in chronic delta hepatitis].
Ramalho F; Velosa J; Costa A; Baptista A; de Moura MC
Acta Med Port; 1993 May; 6(5):187-91. PubMed ID: 8337951
[TBL] [Abstract][Full Text] [Related]
5. Intrahepatic distribution of hepatitis B virus antigens in patients with and without hepatocellular carcinoma.
Safaie P; Poongkunran M; Kuang PP; Javaid A; Jacobs C; Pohlmann R; Nasser I; Lau DT
World J Gastroenterol; 2016 Mar; 22(12):3404-11. PubMed ID: 27022222
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemistry for core and surface antigens in chronic hepatitis.
Sharma RR; Dhiman RK; Chawla Y; Vasistha RK
Trop Gastroenterol; 2002; 23(1):16-9. PubMed ID: 12170914
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis B virus concentrations in serum determined by sensitive quantitative assays in patients with established chronic hepatitis delta virus infection.
Sakugawa H; Nakasone H; Nakayoshi T; Kawakami Y; Yamashiro T; Maeshiro T; Kinjo F; Saito A; Zukeran H
J Med Virol; 2001 Nov; 65(3):478-84. PubMed ID: 11596082
[TBL] [Abstract][Full Text] [Related]
8. Correlation between intrahepatic hepatitis B virus cccDNA levels and other activity markers in patients with HBeAg-negative chronic hepatitis B infection.
Guner R; Karahocagil M; Buyukberber M; Kandemir O; Ural O; Usluer G; Inan D; Koksal I; Baykam N; Hizel K; Yamazhan T; Esen S; Tasyaran MA
Eur J Gastroenterol Hepatol; 2011 Nov; 23(12):1185-91. PubMed ID: 21934508
[TBL] [Abstract][Full Text] [Related]
9. Serum hepatitis B surface antigen and hepatitis B e antigen titers: disease phase influences correlation with viral load and intrahepatic hepatitis B virus markers.
Thompson AJ; Nguyen T; Iser D; Ayres A; Jackson K; Littlejohn M; Slavin J; Bowden S; Gane EJ; Abbott W; Lau GK; Lewin SR; Visvanathan K; Desmond PV; Locarnini SA
Hepatology; 2010 Jun; 51(6):1933-44. PubMed ID: 20512987
[TBL] [Abstract][Full Text] [Related]
10. Liver histology and immunohistochemical findings in asymptomatic Indians with incidental detection of hepatitis B virus infection.
Mukhopadhya A; Ramakrishna B; Richard V; Padankatti R; Eapen CE; Chandy GM
Indian J Gastroenterol; 2006; 25(3):128-31. PubMed ID: 16877824
[TBL] [Abstract][Full Text] [Related]
11. Rapid early HDV RNA decline in the peripheral blood but prolonged intrahepatic hepatitis delta antigen persistence after liver transplantation.
Mederacke I; Filmann N; Yurdaydin C; Bremer B; Puls F; Zacher BJ; Heidrich B; Tillmann HL; Rosenau J; Bock CT; Savas B; Helfritz F; Lehner F; Strassburg CP; Klempnauer J; Wursthorn K; Lehmann U; Manns MP; Herrmann E; Wedemeyer H
J Hepatol; 2012 Jan; 56(1):115-22. PubMed ID: 21762665
[TBL] [Abstract][Full Text] [Related]
12. Expression of Hepatocyte Hepatitis B Core Antigen and Hepatitis B Surface Antigen as a Marker in the Management of Chronic Hepatitis B Patients.
Yim SY; Kim TH; Jun SS; Kim ES; Keum B; Seo YS; Yim HJ; Jeen YT; Chun HJ; Lee HS; Um SH; Kim CD; Won NH; Ryu HS
Gut Liver; 2017 May; 11(3):417-425. PubMed ID: 28208002
[TBL] [Abstract][Full Text] [Related]
13. Expression of HBsAg and HBcAg in liver tissue: correlation with disease activity.
Nakopoulou L; Adraskelas N; Stefanaki K; Zacharoulis D; Hadziyannis S
Histol Histopathol; 1992 Jul; 7(3):493-9. PubMed ID: 1504471
[TBL] [Abstract][Full Text] [Related]
14. [Expression and clinical significance of HBsAg and HBcAg in hepatocytes in chronic hepatitis B].
Wang GS; Wang MM; Xie QL; Ming L; Jiang XN; Chen LW; Liu MH
Zhonghua Gan Zang Bing Za Zhi; 2004 May; 12(5):287-9. PubMed ID: 15161505
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis B surface antigen: relation to hepatitis B replication parameters in HBeAg-negative chronic hepatitis B.
Manesis EK; Papatheodoridis GV; Tiniakos DG; Hadziyannis ES; Agelopoulou OP; Syminelaki T; Papaioannou C; Nastos T; Karayiannis P
J Hepatol; 2011 Jul; 55(1):61-8. PubMed ID: 21145875
[TBL] [Abstract][Full Text] [Related]
16. Intrahepatic expression of hepatitis B core and surface antigens in chronic hepatitis delta-virus infection.
Chu CM; Liaw YF
J Hepatol; 1992 Sep; 16(1-2):153-8. PubMed ID: 1484148
[TBL] [Abstract][Full Text] [Related]
17. [Expressive features of HBsAg and HBcAg in the livers of chronic hepatitis B and its clinical significance].
Le XH; Chen XC; Lin Q; Li MZ; Wang M; Liu SY; Yu ZY; Zhou BP
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2007 Mar; 21(1):41-3. PubMed ID: 17429532
[TBL] [Abstract][Full Text] [Related]
18. Correlation of hepatocyte expression of hepatitis B viral antigens with histological activity and viral titer in chronic hepatitis B virus infection: an immunohistochemical study.
Ramakrishna B; Mukhopadhya A; Kurian G
J Gastroenterol Hepatol; 2008 Nov; 23(11):1734-8. PubMed ID: 18713304
[TBL] [Abstract][Full Text] [Related]
19. [Affects of HBV genotypes (B/C) on the levels of serum and intrahepatic HBsAg].
Chen JJ; Ma SW; Wang ZH; Sun J; Zhu YF; Hou JL
Zhonghua Yi Xue Za Zhi; 2006 Jul; 86(28):1947-51. PubMed ID: 17064586
[TBL] [Abstract][Full Text] [Related]
20. Predictive value of interferon-gamma inducible protein 10 kD for hepatitis B e antigen clearance and hepatitis B surface antigen decline during pegylated interferon alpha therapy in chronic hepatitis B patients.
Wang Y; Zhao C; Zhang L; Yu W; Shen C; Wang W; Zhen Z; Zhou J
Antiviral Res; 2014 Mar; 103():51-9. PubMed ID: 24418572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
